Bicycle Therapeutics

BCYC | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.73

+$0.10 (+2.75%)

Sep 22, 2026, 1:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-218.96M	-169.03M	-180.66M	-112.72M	-66.82M	-51.01M
Depreciation & Amortization	6.42M	7.17M	6.55M	3.69M	1.41M	1.28M
Stock-Based Compensation	39.46M	38.08M	32.48M	26.78M	12.08M	6.51M
Other Working Capital	-71.77M	-24.61M	69.86M	9.46M	37.12M	24M
Other Non-Cash Items	n/a	-2.26M	1.04M	442K	2.14M	751K
Deferred Income Tax	-850K	-5.23M	3.31M	-4.98M	-1.67M	-673K
Change in Working Capital	-75.75M	-33.46M	76.66M	672K	38.07M	25.35M
Operating Cash Flow	-249.68M	-164.72M	-60.63M	-86.11M	-14.79M	-17.79M
Capital Expenditures	-2.36M	-1.24M	-2.93M	-18.99M	-2.03M	-1.2M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	5.49K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-2.35M	-1.24M	-2.93M	-18.99M	-2.03M	-1.2M
Debt Repayment	n/a	-31.91M	n/a	n/a	15M	15M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-168.09K	7.53M	682K	989K	7.18M	-301K
Financial Cash Flow	-131K	519.75M	250.03M	6.69M	320.73M	62.84M
Net Cash Flow	-251.35M	353.1M	187.82M	-99.53M	302.69M	43.87M
Free Cash Flow	-252.61M	-165.96M	-63.56M	-105.1M	-16.82M	-18.99M
Adj. Free Cash Flow	-292.08M	-204.04M	-96.03M	-131.88M	-28.91M	-25.5M
Maintenance CapEx	n/a	n/a	n/a	-16.1M	-1.18M	-1.2M
Growth CapEx	-2.36M	-1.24M	-2.93M	-2.89M	-853.56K	n/a
Owner Earnings	-249.68M	-164.72M	-60.63M	-102.21M	-15.97M	-18.99M